Today, 11th November 2025, a much-anticipated press release from the UK government’s Science Minister Lord Vallance announced its plans to phase out
CN Bio launches all-in-one Organ-on-a-chip system, PhysioMimix® Core
Combines single-organ, multi-organ, and higher-throughput configurations within one scalable platform. Fully compatible with existing PhysioMimix
Regulatory Shifts and Validation: Key Insights from The World Congress on Alternatives and Animal Use in the Life Sciences Conference (WC13)
I, (Dr. Tomasz Kostrweski, CSO, CN Bio) recently had the pleasure of attending the 13th World Congress on Alternatives and Animal Use in the Life
CN Bio adds computational modelling capabilities to ADME services for enhanced bioavailability profiling
CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced
Integrating In Silico Tools with Organ-on-a-Chip to advance ADME studies
Knowing a drug’s bioavailability during lead optimization is crucial as it directly influences dosing strategy, therapeutic efficacy, safety margins,
NIH to prioritize human-based research technologies & reduce animal use in research
During the FDA-NIH Workshop: Reducing Animal Testing, held on July 7, 2025, Dr. Nicole Kleinstreuer, Acting NIH Deputy Director for Program
CN Bio to participate in 3Rs Collaborative-led project with FDA to build confidence in Liver MPS for DILI
Building Confidence in MPS for Regulatory Applications! At the intersection of innovation, collaboration, and science lies an exciting new
CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion CN Bio, a